MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-16-2026
Atara Biotherapeutics EBITDA per Share 2011-2026 | ATRA
Annual EBITDA per Share Atara Biotherapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.03 | -10.5 | -64 | -2.69 | -3.53 | -4.07 | -5.63 | -5.33 | -4.04 | -2.81 | -2.28 | -5.65 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.03 | -64 | -8.96 |
Quarterly EBITDA per Share Atara Biotherapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 3.77 | - | -2.83 | -2.85 | -5.31 | - | -16.1 | -16.8 | -0.71 | - | -0.82 | -0.3 | -0.86 | - | -0.88 | -0.89 | -0.83 | - | -0.89 | -1.12 | -1.19 | - | -1.29 | -1.59 | -1.44 | - | -1.3 | -1.17 | -1.06 | - | -1.03 | -0.95 | -0.89 | - | -0.9 | -0.68 | -0.6 | - | -0.44 | -0.62 | -0.42 | - | - | -3.39 | -5.6 | - | -2.61 | - | - | -5.58 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.77 | -16.8 | -2.29 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M |  USA |
 |
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M |  Canada |
 |
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
-3.63 | - | 10.36 % | $ 9.8 M | USA |
 |
I-Mab
IMAB
|
0.08 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | France |
 |
Ascendis Pharma A/S
ASND
|
-8.25 | $ 219.89 | 2.02 % | $ 5 B |  Danmark |
 |
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | USA |
 |
Omeros Corporation
OMER
|
-2.89 | $ 10.41 | 2.26 % | $ 606 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
3.68 | $ 19.54 | 1.61 % | $ 913 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M |  Israel |
 |
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | USA |
 |
Atreca
BCEL
|
0.14 | - | -11.76 % | $ 5.79 M | USA |
 |
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
0.42 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
bluebird bio
BLUE
|
-1.97 | - | - | $ 546 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - |  Russia |
 |
Cara Therapeutics
CARA
|
-2.24 | - | -3.03 % | $ 260 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | USA |
 |
Processa Pharmaceuticals
PCSA
|
-10.7 | $ 2.33 | - | $ 3.05 M | USA |
 |
Avenue Therapeutics
ATXI
|
-8.71 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-0.92 | $ 1.32 | - | $ 337 M | Britain |
 |
Phathom Pharmaceuticals
PHAT
|
-2.19 | $ 10.41 | 3.48 % | $ 759 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-6.39 | $ 8.29 | 1.28 % | $ 110 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
-7.17 | $ 47.2 | 1.66 % | $ 4.24 B |  Schweiz |
 |
Cyclacel Pharmaceuticals
CYCC
|
-0.54 | - | -5.98 % | $ 34.1 M | USA |
 |
ChemoCentryx
CCXI
|
-1.82 K | - | - | $ 3.74 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
-0.25 | - | - | $ 2.02 B | USA |
 |
BioDelivery Sciences International
BDSI
|
0.38 | - | -4.8 % | $ 255 M | USA |
 |
Enochian Biosciences
ENOB
|
-1.14 | - | - | $ 40.5 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | Germany |
 |
Pliant Therapeutics
PLRX
|
-2.52 | $ 1.31 | 1.95 % | $ 80.4 M | USA |
 |
PMV Pharmaceuticals
PMVP
|
-1.64 | $ 1.38 | -1.08 % | $ 72.5 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
-2.34 | - | -74.18 % | $ 955 K | USA |
 |
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
-0.2 | $ 4.46 | 3.48 % | $ 855 M | Canada |
 |
Homology Medicines
FIXX
|
1.41 | - | 0.77 % | $ 53.4 M | USA |
 |
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | USA |
 |
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
-1.34 | $ 3.28 | 4.97 % | $ 252 M | USA |